What is Mereo BioPharma Group plc American Depositary Shares's Enterprise Value?

Mereo BioPharma Group plc American Depositary Shares's Enterprise Value is $163.5M, based on as-reported figures from SEC (XBRL) filings.

Mereo BioPharma Group plc American Depositary Shares (MREO) Financial Statements

Mereo BioPharma Group plc American Depositary Shares

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00KFWZCX7

XNAS · usd

0.24▼ 0.01 (-4.75%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close0.25

Day's Range0.24 – 0.26

52-Week Range0.20 – 2.37

Volume2.9M

Avg Volume6.8M

Share Statistics

Shares Outstanding

Employees39

ExchangeXNAS

Listed2018-04-24

Share count as of August 7, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Mereo BioPharma Group plc American Depositary Shares (MREO)

What is Mereo BioPharma Group plc American Depositary Shares's Market Cap?: Mereo BioPharma Group plc American Depositary Shares's Market Cap is $193.6M, based on as-reported figures from SEC (XBRL) filings.
What is Mereo BioPharma Group plc American Depositary Shares's Enterprise Value?: Mereo BioPharma Group plc American Depositary Shares's Enterprise Value is $163.5M, based on as-reported figures from SEC (XBRL) filings.
What is Mereo BioPharma Group plc American Depositary Shares's EV / EBITDA?: Mereo BioPharma Group plc American Depositary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Mereo BioPharma Group plc American Depositary Shares's Revenue (TTM)?: Mereo BioPharma Group plc American Depositary Shares's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Mereo BioPharma Group plc American Depositary Shares's Net Income (TTM)?: Mereo BioPharma Group plc American Depositary Shares's Net Income (TTM) is -$28.1M, based on as-reported figures from SEC (XBRL) filings.
What is Mereo BioPharma Group plc American Depositary Shares's EBITDA?: Mereo BioPharma Group plc American Depositary Shares's EBITDA is -$33.5M, based on as-reported figures from SEC (XBRL) filings.
What is Mereo BioPharma Group plc American Depositary Shares's Diluted EPS (TTM)?: Mereo BioPharma Group plc American Depositary Shares's Diluted EPS (TTM) is -0.04, based on as-reported figures from SEC (XBRL) filings.
What is Mereo BioPharma Group plc American Depositary Shares's Net Debt?: Mereo BioPharma Group plc American Depositary Shares's Net Debt is -$30.1M, based on as-reported figures from SEC (XBRL) filings.